In 2023 a record-breaking 13 million hormone replacement therapy (HRT) prescriptions were issued in England, reflecting a 22% increase compared to the previous year, according to newly released NHS data. This surge signifies a growing trend, with more women opting for HRT to manage menopause and perimenopause symptoms.
The latest figures reveal that 2.6 million women in England were prescribed HRT in 2023/24, marking a 12% increase from 2.3 million in 2022/23 and doubling the 1.3 million recorded in 2018/19. The increase is partly attributed to rising awareness, driven by high-profile figures such as Davina McCall and Penny Lancaster, who have been vocal advocates for menopause education and treatment options.
Increased Awareness Leading to Record Demand
The significant uptick in HRT usage highlights the impact of public advocacy in demystifying menopause. Celebrities, including Davina McCall, have used their platforms to share their personal experiences, encouraging women to seek information and treatment for menopause symptoms. This has led to a broader acceptance of discussing menopause openly, empowering women to take control of their health.
McCall, who has been a leading voice on the topic, shared her disappointment earlier this year over a recent documentary that she felt downplayed the benefits of HRT. Despite mixed media coverage, her message has resonated, as evidenced by the rising prescription rates.
Who Is Taking HRT?
The data shows that women aged 50-54 were the largest demographic for HRT prescriptions, with 640,000 women in this age group accounting for nearly 25% of all HRT users in 2023/24.
The increase in HRT prescriptions was also observed across other age groups, reflecting a growing awareness of treatment options for both perimenopausal and menopausal women.
Understanding Hormone Replacement Therapy
HRT is used to replace hormones such as oestrogen and progesterone in women experiencing perimenopause or menopause. Available in various forms—tablets, gels, creams, and patches—HRT helps alleviate symptoms like hot flushes, anxiety, and insomnia, significantly improving the quality of life for many women.
While HRT has been associated with a slight increase in the risk of breast cancer, the NHS emphasizes that the overall risk of serious side effects is very low. Medical professionals encourage women to weigh the benefits and risks and consult with their doctors to determine the best treatment plan.
Cost and Accessibility
As of 2024, the cost of a 12-month HRT prescription in England is £19.80, offering a more affordable option compared to purchasing the medication on a per-treatment basis. This reduced cost initiative, implemented earlier this year, aims to make HRT more accessible, helping to alleviate financial burdens for women seeking long-term treatment.
A Growing Movement for Change
The surge in HRT prescriptions reflects broader social changes, with more women advocating for greater understanding and access to menopause treatment. The NHS has responded by improving access to information and services, and campaigns to educate the public are becoming more prevalent. For those experiencing menopausal symptoms, the NHS recommends visiting their website or consulting with a healthcare professional for more guidance.
What’s Next?
Efforts to improve women’s health continue to grow. The NHS and advocates like Davina McCall are working to ensure women have the resources and support needed to navigate menopause confidently. With increasing prescription rates and greater awareness, the conversation around menopause and HRT is shifting, paving the way for more informed and supportive approaches to women’s health.
For more information on HRT and managing menopause symptoms, visit the NHS website or consult your GP.
Comments